©The Author(s) 2025.
World J Gastrointest Surg. Nov 27, 2025; 17(11): 110490
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.110490
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.110490
Table 2 Clinical stage and surgical outcomes of patients with perforated gastric cancer according to initial surgical approach - primary perforation repair and one-stage gastrectomy groups, n (%)
| Variables | Primary perforation repair, n = 26 | One-stage gastrectomy, n = 10 | P value |
| cT | 1.0 | ||
| < T4a | 14 (53.8) | 5 (50) | |
| cT4b | 12 (46.2) | 5 (50) | |
| cN | 0.484 | ||
| cN0 | 1 (3.8) | 1 (10) | |
| cN+ | 5 (96.2) | 9 (90) | |
| cM | 0.137 | ||
| cM0 | 11 (42.3) | 7 (70) | |
| cM1 | 15 (57.7) | 3 (30) | |
| cTNM | 0.324 | ||
| ≤ III | 4 (15.4) | 2 (20) | |
| IVA | 7 (26.9) | 5 (50) | |
| IVB | 15 (57.7) | 3 (30) | |
| Preoperative chemotherapy | 0.397 | ||
| No | 19 (73.1) | 9 (90) | |
| Yes | 7 (26.9) | 1 (10) | |
| Length of hospital stay (days) | 0.185 | ||
| Median (IQR) | 11 (5-20) | 13.5 (10-37) | |
| Postoperative complication (Clavien-Dindo) | 1.000 | ||
| 0-I-II | 9 (34.6) | 3 (30) | |
| III-V | 18 (69.2) | 7 (70) | |
| Clavien V | 0.260 | ||
| No | 9 (35.6) | 6 (60) | |
| Yes | 17 (65.4) | 4 (40) | |
| Mortality | |||
| 30-day | 16 (61.5) | 3 (30) | 0.139 |
| 90-day | 17 (65.4) | 3 (30) | 0.073 |
- Citation: Aguiar MFF, Pereira MA, Dias AR, Ribeiro Jr U, Ramos MFKP. Surgical treatment of perforated gastric tumors. World J Gastrointest Surg 2025; 17(11): 110490
- URL: https://www.wjgnet.com/1948-9366/full/v17/i11/110490.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i11.110490